Topotecan versus treosulfan, an alkylating agent, in patients with epithelial ovarian cancer and relapse within 12 months following 1st-line platinum/paclitaxel chemotherapy. A prospectively randomized phase III trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (A

W. Meier,A. du Bois,A. Reuss,W. Kuhn,S. Olbricht,M. Gropp,B. Richter,H. Lück,R. Kimmig,J. Pfisterer
DOI: https://doi.org/10.1016/j.ygyno.2009.04.026
IF: 5.304
2009-08-01
Gynecologic Oncology
Abstract:
What problem does this paper attempt to address?